secwatch.observer — SEC 8-K summary
======================================

Issuer:     Atea Pharmaceuticals, Inc. (AVIR)
CIK:        0001593899
Form:       8-K
Filed at:   2026-06-22T20:53:52+00:00
Accession:  0001193125-26-277639
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Atea stockholders reelect all three Class III directors; KPMG ratified; say-on-pay passes
--------------------------------------------------------------------------------

- Jerome Adams, Howard Berman, Barbara Duncan elected as Class III directors (for votes: 28.8M, 44.5M, 43.7M).
- Ratification of KPMG as auditor for FY2026: 58.9M for, 0.78M against, 65.5K abstain.
- Advisory approval of exec compensation: 47.5M for, 3.0M against, 643.6K abstain; broker non-vote 8.7M.
- Approximately 74.65% of outstanding shares represented at the meeting (59.7M shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1593899/000119312526277639/0001193125-26-277639-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1593899/000119312526277639/d11075d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-277639

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer